Article
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Journal of the National Cancer Institute - 1 Sept 2018
Bradbury Angela R, Patrick-Miller Linda J, Egleston Brian L, Hall Michael J, Domchek Susan M, Daly Mary B, Ganschow Pamela, Grana Generosa, Olopade Olufunmilayo I, Fetzer Dominique, Brandt Amanda, Chambers Rachelle, Clark Dana F, Forman Andrea, Gaber Rikki, Gulden Cassandra, Horte Janice, Long Jessica M, Lucas Terra, Madaan Shreshtha, Mattie Kristin, McKenna Danielle, Montgomery Susan, Nielsen Sarah, Powers Jacquelyn, Rainey Kim, Rybak Christina, Savage Michelle, Seelaus Christina, Stoll Jessica, Stopfer Jill E, Yao Xinxin Shirley
Abstract excerpt
Background: Germline genetic testing is standard practice in oncology. Outcomes of telephone disclosure of a wide range of cancer genetic test results, including multigene panel testing (MGPT) are unknown. Methods: Patients undergoing cancer genetic testing were recruited to a multicenter, randomized, noninferiority trial (NCT01736345) comparing telephone disclosure (TD) of genetic test results with usual care,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
